Search…

Hengrui Medicine: The application for the market approval of Adcetris injection for new indications has been accepted by the National Medical Products Administration.

23/09/2025

Hengrui Pharmaceuticals announced that its subsidiary, Shanghai Shengdi Pharmaceutical Co., Ltd., has received a "Notice of Acceptance" issued by the National Medical Products Administration. The company's drug for the new indication of Adcetris Injection has been accepted for market approval application by the National Medical Products Administration.

Latest

2 m ago

Meta: Gradually take measures to expand access permissions to LLAMA.

3 m ago

Ean: GAC Group has always respected and accepted suggestions and supervision from all sectors of society, but the internet is not a lawless place. We will adopt a zero-tolerance attitude towards malicious rumors and actions that harm the interests of the company and individuals, and will continue to use legal means to uphold the company's legitimate rights and interests. Let's work together with all sectors of society to build a clean online environment.

3 m ago

The celebration of the 70th anniversary of the founding of the Xinjiang Uygur Autonomous Region will be held in Urumqi on the morning of the 25th, and Xi Jinping will attend the meeting.

3 m ago

ST Huicheng: Signing of "Financial restructuring investment agreement"

4 m ago

National United Resources (00254.HK) issued a profit warning, expecting the annual net loss attributable to owners of the company to increase to approximately HK$50 million to HK$60 million.

See all latest